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Importance 
Contagious bovine pleuropneumonia (CBPP) is one of the most important 
infectious diseases of cattle in Africa. Naïve herds can experience losses up to 80%, 
and many cattle that survive remain chronic carriers. These carriers may suffer from 
recurrent low-grade fever, loss of condition, and respiratory signs upon exercise, and 
might introduce the virus into uninfected herds. Although contagious bovine 
pleuropneumonia was once found worldwide, it was eradicated from most continents, 
including North America, by the mid-20
th
 century. Its incidence also began to decline 
in Africa by the 1970s. During the late 1980s and 1990s, however, this disease 
increased in prevalence in endemic areas. It also re-emerged in some African and 
European countries that had been CBPP-free, in some cases for 25 years or more. 
Eradication was successful in Europe, with the most recent case reported in 1999. 
However, contagious bovine pleuropneumonia remains a serious concern in Africa, 
where the end of widespread combined rinderpest/CBPP vaccination programs (after 
rinderpest eradication) may have contributed to its resurgence. 
Etiology 
Contagious bovine pleuropneumonia is caused by Mycoplasma mycoides subsp. 
mycoides, a member of the Mycoplasma mycoides cluster in the family 
Mycoplasmataceae. This organism was previously specified as the small-colony (SC) 
type of this organism; however, Mycoplasma mycoides subsp. mycoides large colony 
type no longer exists (these organisms are now considered to belong to M. mycoides 
subsp. capri). Nevertheless, many sources continue to use the full designation 
Mycoplasma mycoides subsp. mycoides SC. M. mycoides SC can be grouped into at 
least two major lineages (African and European), or into at least 3 or 4 genetic 
groups. Strains can differ in virulence. 
Zoonotic potential 
There is no evidence that humans are infected by M. mycoides SC. 
Species Affected 
Cattle (Bos taurus and Bos indicus) and Asian buffalo (Bubalus bubalis) are the 
primary hosts for M. mycoides SC. Clinical cases have also been reported in yak 
(Poephagus grunniens/ Bos grunniens) and captive bison (Bison bison). Sheep and 
goats can be infected, although they are not thought to be important in the 
epidemiology of CBPP. White-tailed deer (Odocoileus virginianus) have been 
infected experimentally. There is little published surveillance for M. mycoides SC in 
wildlife, with the exception of two studies conducted before 1970, which reported that 
African wildlife were unlikely to be infected. 
Geographic Distribution  
Contagious bovine pleuropneumonia is endemic in parts of Africa. Sporadic 
outbreaks have been reported in the Middle East, and are probably caused by cattle 
imported from Africa. There is limited information about Asian countries in the most 
recent reports to the World Organization for Animal Health (OIE), although some 
countries have indicated that they are CBPP-free. M. mycoides SC is not currently 
endemic in Europe or the Western Hemisphere.  
Transmission 
M. mycoides SC is mainly transmitted from animal to animal in respiratory 
aerosols. This organism also occurs in saliva, urine, fetal membranes and uterine 
discharges. Close, repeated contact is generally thought to be necessary for 
transmission; however, M. mycoides SC might be spread over longer distances (up to 
200 meters) if the climatic conditions are favorable. Carrier animals, including 
subclinically infected cattle, can retain viable organisms in encapsulated lung lesions 
(sequestra) for several months or more (one source indicates up to two years). These 
animals are thought to be capable of shedding organisms, particularly when stressed. 
Transplacental transmission is also possible.  
 
 
Contagious Bovine Pleuropneumonia 
Last Updated: November 2015 © 2008-2015 page 2 of 5 
Although there are a few anecdotal reports of 
transmission on fomites, mycoplasmas do not survive for 
more than a few days in the environment and indirect 
transmission is thought to be unimportant in the 
epidemiology of this disease. 
Disinfection 
Mycoplasma spp. are generally short-lived, fragile 
organisms in the environment. If disinfection is needed, 
they are reported to be susceptible to many disinfectants 
including 1% sodium hypochlorite, 70% ethanol, phenolic 
disinfectants, iodophores, formaldehyde, glutaraldehyde, 
and peracetic acid. 
Incubation Period 
The incubation period for contagious bovine 
pleuropneumonia can be 3 weeks to 6 months, with most 
cases becoming apparent in 3-8 weeks. After experimental 
inoculation of large doses into the trachea, the clinical signs 
appeared in 2 to 3 weeks. 
Clinical Signs 
A few cattle with CBPP may die peracutely with no 
clinical signs other than fever. Acute cases in cattle are 
characterized by nonspecific signs of fever, loss of appetite, 
depression and a drop in milk production, followed by 
respiratory signs, which may include coughing, purulent or 
mucoid nasal discharges, and rapid respiration. Clinical signs 
can differ in severity between outbreaks, but some cases 
progress rapidly to dyspnea. Respiration can be painful, and 
animals may react intensely if pressed between the ribs. 
Severely affected cattle may stand with their head and neck 
extended and forelegs apart, breathing through the mouth. 
The throat and dewlap sometimes swell. Epistaxis and 
diarrhea have also been reported, and pregnant animals may 
abort or give birth to stillborn calves. Severely affected cattle 
often die, typically within three weeks. Animals that recover 
are frequently weak and emaciated, and may remain 
chronically infected. Subclinical infections also occur. 
In calves up to six months of age, the primary sign may 
be polyarthritis, especially of the carpal and tarsal joints, 
often without respiratory signs. The affected joints may be 
so painful that the animal is very reluctant to bend them.  
Chronic CBPP is characterized by recurrent low-grade 
fever, loss of condition, and respiratory signs that may be 
apparent only when the animal is exercised. Many cattle 
eventually recover fully, although the lung lesions can take 
a long time to heal.  
The effects of M. mycoides SC on small ruminants are 
still unclear. There have been reports of its isolation from 
sheep with mastitis and goats with respiratory disease. 
Other agents, including other mycoplasmas, were also 
detected in some outbreaks, but not others. Experimentally 
infected sheep remained asymptomatic, although some 
animals had a slight cough, and slight lesions of interstitial 
pneumonia (evident only microscopically) were found in 
the lungs. In another study, goats in close contact with 
experimentally infected cattle did not become infected. One 
of two experimentally infected white-tailed deer developed 
a fever and died with severe respiratory lesions; the second 
deer remained healthy.  
Post Mortem Lesions      Click to view images 
The lesions of CBPP are often unilateral. In acute 
disease, large amounts of straw-colored fluid may be present 
in the thoracic cavity and pericardial sac. The lymph nodes of 
the chest are enlarged and edematous, and may contain 
petechiae and small necrotic foci. The lungs are consolidated 
and typically marbled; areas of different color (pale pink, red 
and dark red) may be separated by a network of pale bands. 
Extensive fibrin accumulation can be found on the pleural 
surfaces and within the interlobular septa, causing 
enlargement of the septa. The fibrin is replaced by fibrous 
connective tissue over time. Fluid is not usually seen in 
chronic cases, but pleural adhesions are common. Necrotic 
lung tissue becomes encapsulated, forming pulmonary 
sequestra that may contain viable organisms. These sequestra 
are 2 cm to 25 cm in diameter and are surrounded by a 
fibrous connective tissue capsule up to 1 cm thick. The 
necrotic tissue in the sequestrum is odorless and can retain its 
lobular structure as it shrinks and dries, although it may later 
liquefy. Sequestra deep in the lung may not be seen, but can 
be palpated. Sequestra can be found even in recovered 
animals. Lesions considered to be typical of CBPP, such as 
marbling of lung tissue and the presence of sequestra, have 
been absent in some confirmed cases.  
In calves with poly-arthritis, affected joints are filled 
with fluid and abundant fibrin. Infarcts, appearing as 
chronic fibrotic foci, may be found in the kidneys of these 
animals. 
A fatal case in an experimentally infected deer was 
characterized by pneumonia with secondary hemorrhages; 
however, marbling, sequestra, fibrinous adhesions and 
excessive pleural fluid were absent. 
Diagnostic Tests 
In live animals, a definitive diagnosis can be made by 
detecting M. mycoides SC in nasal swabs or discharges, 
bronchoalveolar lavage or transtracheal wash fluid, pleural 
fluid, or synovial fluid from swollen joints. At necropsy, the 
organism is most likely to be found in lung lesions, pleural 
fluid and regional lymph nodes of the respiratory tract. 
Ideally, lung samples should be collected at the interface 
between diseased and normal tissue. Recent European 
isolates have sometimes been recovered from the lungs of 
animals without typical CBPP lesions. Isolation from blood 
or the kidneys may also be successful. Members of the 
Mycoplasma mycoides cluster cross-react in serological 
tests and share biochemical and antigenic similarities, 
complicating the identification of CBPP unless genetic tests 
such as polymerase chain reaction (PCR) assays are used. 
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A definitive diagnosis can be made by recovering M. 
mycoides SC from infected animals. Isolation may not be 
successful after antibiotics have been used, and cultures 
from sequestra in chronic cases are often negative. Culture 
can be performed on standard mycoplasma media. This 
organism is usually identified by PCR, although 
biochemistry and serological methods (growth inhibition, 
immunofluorescence, dot immunobinding on a membrane 
filter [MF-dot] test, agar gel immunodiffusion) can also be 
employed and were used more frequently in the past. 
Biochemical tests are unable to unequivocally identify the 
members of the M. mycoides cluster, and serological 
identification is hampered by cross-reactivity. There have 
been reports of unusual field isolates (e.g., M375 from 
Botswana) that were more fastidious than expected and had 
altered colony morphology, unique polymorphisms 
following immunoblotting, and altered properties in 
growth-inhibition and biochemical tests. 
PCR assays are more likely to be successful than 
culture, and can be used to identify M. mycoides SC directly 
in clinical samples. At least one isothermal loop-mediated 
amplification method has also been published. Various 
antigen detection tests (e.g., 
immunofluorescence/immunohistochemistry, antigen-
capture ELISA, agar gel immunodiffusion, interface 
precipitin test, lateral flow assay) have been described or 
used in diagnosis.  
Serology is generally employed at the herd level (i.e., 
in screening and eradication programs), rather than as a 
diagnostic test in individual animals. Animals may not 
develop measurable titers in the early stages of CBPP, and 
few animals with chronic disease are seropositive. 
Serological tests include complement fixation (CF), ELISA, 
immunoblotting (generally as a confirmatory test for CF or 
ELISA), and a rapid slide agglutination test (SAT). The 
SAT is relatively insensitive and can only identify animals 
in the acute stage of disease. Other mycoplasmas, 
particularly other members of the M. mycoides cluster, can 
result in false positive reactions in serological assays. 
Treatment 
Tetracyclines, macrolides and fluoroquinolones are 
reported to be useful in treatment, but individual drugs may 
differ in their effects. Complete elimination of 
mycoplasmas is reported to be rare. The degree of risk from 
treated animals is still uncertain; however, treatment is 
controversial, and some countries do not permit antibiotics 
to be used. Antibiotics are reported to be ineffective in 
chronic cases.  
Control 
Disease reporting 
A quick response is vital for containing outbreaks in 
regions free of contagious bovine pleuropneumonia. 
Veterinarians who encounter or suspect this disease should 
follow their national and/or local guidelines for disease 
reporting. In the U.S., state or federal veterinary authorities 
should be informed immediately. 
Prevention 
CBPP is most likely to be introduced in an infected 
animal or embryo, as the organism does not survive for 
long periods on fomites. Quarantines and serological testing 
of imported animals are helpful. Outbreaks are eradicated 
with quarantines, movement controls, slaughter of infected 
and in-contact animals, and cleaning and disinfection.  
Vaccines are used to control CBPP in endemic areas. 
On-farm quarantine of CBPP suspects (both clinically 
affected and carrier animals) and contact animals is helpful 
in controlling the spread of disease. 
Morbidity and Mortality 
The morbidity and mortality rates for CBPP are highly 
variable. In a naïve herd, the outcome varies from complete 
recovery of all animals to the death of the majority. 
Morbidity increases with close confinement, due to the 
increase in transmission, and infection rates can be as high 
as 50-80% in some situations. The mortality rate ranges 
from 10% to 80%, although mortality greater than 50% is 
reported to be uncommon. The severity of the illness can 
also be affected by the virulence of the strain, and 
secondary factors in the animal, such as nutrition and 
parasitism. There may be breed-related differences in 
susceptibility.  
African and recent European isolates may differ in 
virulence. When they are first introduced into a naïve herd, 
African isolates usually cause acute disease, severe clinical 
signs and high mortality. Once the disease has become 
established, the mortality rate falls and the number of 
animals with chronic disease rises. Much milder illnesses 
were reported during the recent outbreaks in Europe, and 
affected animals usually developed subacute or chronic 
disease. The morbidity rate was generally low (for example, 
less than 5% in one Italian herd), and few animals died. The 
decreased severity of CBPP in Europe might also be related 
to animal husbandry and the availability of antibiotics and 
anti-inflammatory drugs  
For More Information 
FAO. Recognizing Contagious Bovine Pleuropneumonia.  
ftp://ftp.fao.org/docrep/fao/005/y4142E/y4142E00.pdf  
The Merck Veterinary Manual  
http://www.merckvetmanual.com/mvm/index.html 
United States Animal Health Association.  
Foreign Animal Diseases  
http://www.aphis.usda.gov/emergency_response/downlo
ads/nahems/fad.pdf 
World Organization for Animal Health (OIE) 
http://www.oie.int  
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OIE Manual of Diagnostic Tests and Vaccines for  
Terrestrial Animals 
http://www.oie.int/international-standard-
setting/terrestrial-manual/access-online/  
OIE Terrestrial Animal Health Code 
http://www.oie.int/international-standard-
setting/terrestrial-code/access-online/ 
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